Hematologic Oncology Update

Featuring an interview with Dr Matthew Lunning, including the following topics:
Bispecific antibody/antibody-drug conjugate combinations (0:00)
A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07)

CME information and select publications

Featuring a presentation by Dr Matthew Matasar, including the following topics:
Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)
Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)
Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)
Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)
Discussion of Questions from the Community (50:20)

CME information and select publications

Featuring an interview with Dr Matthew Lunning, including the following topics:
A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP — Ann LaCasce, MD, MMSc (0:00)
CNS prophylaxis in non-Hodgkin lymphoma (7:58)

CME information and select publications

Featuring perspectives from Dr Lindsey Roeker, including the following topics:
Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line venetoclax/obinutuzumab and experiences an excellent response (0:00)
Case: A man in his late 70s with small lymphocytic lymphoma (SLL) and cardiovascular comorbidities requiring verapamil and anticoagulation receives acalabrutinib/venetoclax; Case: A man in his early 80s with SLL receives zanubrutinib/sonrotoclax as part of the CELESTIAL-TNCLL trial (14:46)
Case: A man in his late 70s with progressive CLL worsening after a skiing injury receives acalabrutinib/venetoclax as part of the MAJIC trial (22:37)

CME information and select publications

Featuring perspectives from Dr Lindsey Roeker, including the following topics:
Consensus Approach to optimizing front-line treatment (0:00)
Emerging role of sonrotoclax (8:39)
Bruton tyrosine kinase inhibitor monotherapy for older patients; discontinuation (14:48)
Evolving role of minimal residual disease assessment (19:16)

CME information and select publications